Maximus has increased its quarterly cash dividend to $0.33 per share, representing a 10% uplift from the previous payout of $0.30. This marks the company’s eighth consecutive year of dividend growth, reflecting its strong free cash flow generation and commitment to returning capital to shareholders. The new dividend level will be payable on February 15 to shareholders of record as of January 31, positioning Maximus among a select group of mid-cap health services firms with a growing yield profile.

In its latest Form 13F filing, Cwm LLC disclosed a 102.9% increase in its Maximus shareholdings during Q3, boosting its position by 7,452 shares to a total of 14,696 shares. The newly acquired stake was valued at approximately $1.34 million as of the quarter’s end, up from $657,000 prior. This move underscores growing institutional confidence in Maximus’s government services portfolio following modest organic revenue gains in core Medicaid and human services lines.

Maximus reported third-quarter EPS of $1.62, narrowly missing consensus by one cent, on revenues of $1.32 billion versus expectations of $1.34 billion. Year-over-year revenue improved by 0.2%, driven by higher enrollment services volume. Return on equity stood at 25.2% and net margin at 5.9%. Management reiterated full-year 2026 EPS guidance in a range of $7.95 to $8.25, reflecting anticipated contract renewals and modest growth in call center operations.

Following the Q3 release, one sell-side analyst upgraded Maximus to a Strong Buy, while another maintained a Buy rating, yielding an average recommendation of Strong Buy. Hedge funds and other institutions collectively hold 97.21% of the company’s shares, with recent position increases also reported at Parkside Financial Bank & Trust (+21.7% in Q2), GAMMA Investing LLC (+13.9% in Q3) and Trust Point Inc. (+3.7% in Q3), signaling continued top-tier investor support.